The Foundation’s commitment to these principles will continue to be a cornerstone of the Foundation’s work to advance our mission in 2023.
Site Search
Showing 1 - 6 of 6 results
News
|
Jan. 19, 2023
|
4 min read
The Cystic Fibrosis Foundation’s investment will go toward conducting preclinical research on a novel gene delivery vehicle. If successful, this gene delivery method could overcome some of the biggest challenges to delivering a gene therapy into the lung cells of people with cystic fibrosis.
News
|
Jan. 9, 2023
|
2 min read
A transformative leader for more than two decades, Marshall will transition to advisory role
News
|
March 6, 2024
|
3 min read
The funding will help support research into the development of potential new modulator therapies for people with cystic fibrosis with an F508del mutation.
News
|
March 7, 2024
|
2 min read
Funding will support a Phase 2b trial of phage therapy for chronic Pseudomonas aeruginosa lung infections.
News
|
March 18, 2024
|
2 min read
This year’s program marked the largest in-person advocacy event in the Foundation’s history.
News
|
March 19, 2024
|
3 min read